$VRTX VERTEX PHARMACEUTICALS INC / MA Insider Trading Week 17/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA in week 17/2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | WAGNER CHARLES F JR | EVP and CFO | Payment of Exercise | F | 251.78 | 547 | 137,724 | 16,727 | 17.3 K to 16.7 K (-3.17 %) |
| May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Option Exercise | M | 90.29 | 2,125 | 191,866 | 2,125 | |
| May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 258.15 | 100 | 25,815 | 26,838 | 26.9 K to 26.8 K (-0.37 %) |
| May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 256.63 | 500 | 128,315 | 26,938 | 27.4 K to 26.9 K (-1.82 %) |
| May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 255.44 | 680 | 173,699 | 27,438 | 28.1 K to 27.4 K (-2.42 %) |
| May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 254.20 | 400 | 101,680 | 28,118 | 28.5 K to 28.1 K (-1.40 %) |
| May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 252.70 | 300 | 75,810 | 28,518 | 28.8 K to 28.5 K (-1.04 %) |
| May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 251.38 | 145 | 36,450 | 28,818 | 29 K to 28.8 K (-0.50 %) |
| May 01 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Buy | M | 90.29 | 2,125 | 191,866 | 28,963 | 26.8 K to 29 K (+7.92 %) |
| Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 1,125 | 64,429 | 0 | |
| Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 261.80 | 116 | 30,369 | 1,875 | 2 K to 1.9 K (-5.83 %) |
| Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 260.53 | 180 | 46,895 | 1,991 | 2.2 K to 2 K (-8.29 %) |
| Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 259.61 | 120 | 31,153 | 2,171 | 2.3 K to 2.2 K (-5.24 %) |
| Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 258.53 | 120 | 31,024 | 2,291 | 2.4 K to 2.3 K (-4.98 %) |
| Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 257.20 | 149 | 38,323 | 2,411 | 2.6 K to 2.4 K (-5.82 %) |
| Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 255.79 | 240 | 61,390 | 2,560 | 2.8 K to 2.6 K (-8.57 %) |
| Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 254.81 | 200 | 50,962 | 2,800 | 3 K to 2.8 K (-6.67 %) |
| Apr 29 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 1,125 | 64,429 | 3,000 | 1.9 K to 3 K (+60.00 %) |
| Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 2,000 | 114,540 | 1,125 | |
| Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Option Exercise | M | 57.27 | 2,000 | 114,540 | 3,125 | |
| Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 273.44 | 100 | 27,344 | 1,875 | 2 K to 1.9 K (-5.06 %) |
| Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 272.51 | 200 | 54,502 | 1,975 | 2.2 K to 2 K (-9.20 %) |
| Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 271.56 | 1,113 | 302,246 | 2,175 | 3.3 K to 2.2 K (-33.85 %) |
| Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 270.37 | 394 | 106,526 | 3,288 | 3.7 K to 3.3 K (-10.70 %) |
| Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 268.40 | 193 | 51,801 | 3,682 | 3.9 K to 3.7 K (-4.98 %) |
| Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 2,000 | 114,540 | 3,875 | 1.9 K to 3.9 K (+106.67 %) |
| Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 270.30 | 120 | 32,436 | 1,875 | 2 K to 1.9 K (-6.02 %) |
| Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 269.28 | 400 | 107,712 | 1,995 | 2.4 K to 2 K (-16.70 %) |
| Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 268.31 | 590 | 158,303 | 2,395 | 3 K to 2.4 K (-19.77 %) |
| Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Sell | S | 267.23 | 890 | 237,835 | 2,985 | 3.9 K to 3 K (-22.97 %) |
| Apr 28 2020 | VRTX | VERTEX PHARMACEUTI ... | Lee Yuchun | Director | Buy | M | 57.27 | 2,000 | 114,540 | 3,875 | 1.9 K to 3.9 K (+106.67 %) |